DaRT radiation therapy for prostate cancer that has returned
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new type of radiation using tiny alpha-emitting seeds placed directly into the tumor. It is for people whose prostate cancer came back in the gland after initial treatment but hasn't spread elsewhere.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prostate cancer came back just in the prostate gland, confirmed by a biopsy and imaging within the last 6 months.
- The tumor can be seen on a PSMA PET or multiparametric MRI scan.
- Your doctor already recommended a type of focal salvage radiation called brachytherapy.
- The largest tumor is 3 centimeters or less, and the seeds can fully cover it.
- Your PSA level is less than 10 ng/mL before starting this treatment.
- You are 18 or older, able to care for yourself, and expected to live more than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using tiny alpha radiation implants directly into the prostate for prostate cancer that has come back after initial treatment. It may be an option for people with a local recurrence who are eligible for focal salvage therapy.
This trial tests a treatment that places tiny radiation “seeds” inside/near the chest tumor to treat recurrent lung cancer. It may help people whose cancer has come back and can be safely reached by the radiation device.
This trial tests a targeted radiation device (DaRT seeds) to treat certain cancers on the skin, in the mouth, or in superficial soft tissue. It may help when standard treatment (like surgery or regular radiation/chemo) hasn’t worked, isn’t safe, or isn’t wanted.
This trial tests a new type of radiation therapy (DaRT) that uses tiny, implantable seeds to deliver targeted alpha radiation to breast tumors. It is designed for older patients (65+) or those who are too frail for surgery, offering a less invasive option for controlling the cancer.
This study tests a radiation-emitting device (called DaRT) for treating cancer tumors. It may help shrink or control malignant tumors and researchers will check safety and response to the treatment.
This trial tests a radiation treatment that places tiny radioactive seeds directly into the tumor to treat advanced pancreatic cancer. It mainly focuses on safety and whether the treatment can be delivered effectively, especially for people who may not be able to have more chemotherapy or surgery.
Hear when a new Locally Recurrent Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.